|
Neonatal respiratory distress
|
HP_0002643 |
[Respiratory difficulty as newborn.] |
|
Respiratory insufficiency
|
HP_0002093 |
[Impairment of gas exchange within the lungs secondary to a disease process, neoplasm, or trauma, possibly resulting in hypoxia, hypercarbia, or both, but not requiring intubation or mechanical ventilation. Patients are normally managed with pharmaceutical therapy, supplemental oxygen, or both.] |
|
type I interferon signaling pathway
|
GO_0060337 |
[A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.] |
|
umifenovir
|
CHEBI_134730 |
|
|
B cell
|
CL_0000236 |
[A lymphocyte of B lineage that is capable of B cell mediated immunity.] |
|
macrophage
|
CL_0000235 |
[A mononuclear phagocyte present in variety of tissues, typically differentiated from monocytes, capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells.] |
|
thalidomide
|
CHEBI_9513 |
[A racemate comprising equimolar amounts of R- and S-thalidomide.] |
|
kidney failure
|
DOID_1074 |
[A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood.] |
|
virus receptor activity
|
GO_0001618 |
[Combining with a virus component and mediating entry of the virus into the cell.] |
|
Abnormality of immune serum protein physiology
|
HP_0011111 |
[An abnormality of the concentration or function of circulating immune proteins.] |
|
Abnormality of serum cytokine level
|
HP_0011112 |
[Abnormality of the cytokine levels in the blood, i.e., an abnormality of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells.] |
|
Human herpesvirus 8 strain rKSHV.219
|
NCBITaxon_651668 |
|
|
mature T cell
|
CL_0002419 |
[A T cell that expresses a T cell receptor complex and has completed T cell selection.] |
|
SARS coronavirus Rs_672/2006
|
NCBITaxon_722424 |
|
|
realizable entity
|
BFO_0000017 |
|
|
Lopinavir/Ritonavir
|
NCIT_C2096 |
[A fixed combination of two protease inhibitors, lopinavir and ritonavir, used to treat human immunodeficiency virus (HIV) infection. The ritonavir in the combination drug increases the concentration and biological half-life of lopinavir but is not present in sufficient concentration to act as a protease inhibitor.] |
|
simeprevir
|
CHEBI_134743 |
|
|
treatment
|
OGMS_0000090 |
[A planned process whose completion is hypothesized by a health care provider to eliminate, prevent, or alleviate the signs and symptoms of a disorder or pathological process] |
|
IL18
|
OGG_3000003606 |
|
|
Interferon Alfa-2b
|
DRON_00017633 |
[A non-glycosylated recombinant interferon with antiviral and antineoplastic activities. Alfa interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects.] |